Companies: 10,795·Total market cap: $144.5T
Rhino Biotech Limited

Rhino Biotech Limited

RBRXFOTCFinancial Services
$0.00
+$0.00(+9900.00%)
Market Cap$3105
P/E Ratio—
52W High$0.0001
52W Low$0.000001
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Rhino Biotech Limited (RBRXF) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001278465 · RBRXF · OTC · as of Jun 10, 2026

Filing snapshot

151
Total Filings
REVOKED
Latest Form
2025-03-06
Most Recent
2005
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001278465 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2021-05-17
Fiscal Year End
May 17, 2021
Accession No.
0001654954-21-005825
Primary Document
euenf_20f.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001278465 · Accession 0001654954-21-005825

Latest Key Filings

6-KQuarterly Report
REPORT OF FOREIGN PRIVATE ISSUER
2023-09-05
View 6-K on SEC
8-KCurrent Report
EURASIA ENERGY LTD. FORM 8-K
2008-04-29Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
REVOKEDREVOKED
REVOKED
2025-03-06
View
NT 20-FNT 20-F
NOTIFICATION OF LATE FILING
2024-05-02
View
NT 20-FNT 20-F
NOTIFICATION OF LATE FILING
2024-05-02
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2023-09-05
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2022-05-05
View
NT 20-FNT 20-F
NOTIFICATION OF LATE FILING
2022-05-03
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2022-04-28
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2022-04-04
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2022-03-14
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2022-01-20
View
20-FAnnual Report (Foreign Issuer)
FORM 20-F
2021-05-17
View
NT 20-FNT 20-F
PRIMARY DOCUMENT
2021-04-30
View
20-FAnnual Report (Foreign Issuer)
20-F
2020-04-30
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2019-10-11
View
20-FAnnual Report (Foreign Issuer)
PRIMARY DOCUMENT
2019-05-14
View
Showing 1–15 of 125 filingsForm 4 / 144 hidden· 151 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001278465  |  Exchange: OTC · Financial Services

Rhino Biotech Limited (OTC: RBRXF) has submitted 151 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2005. As a Financial Services sector company with CIK 0001278465, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Rhino Biotech Limited's most comprehensive regulatory disclosure. The most recent Rhino Biotech Limited 10-K was filed on 2021-05-17 for fiscal year ending 2021. Historical RBRXF 10-K annual reports are available from 2004 through 2021.

Investors researching Rhino Biotech Limited SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-10
Related Companies SEC Filings — Financial Services
CONC SEC Filings →ZIPL SEC Filings →ANSU SEC Filings →PLYN SEC Filings →SSCR SEC Filings →WWSG SEC Filings →AFHIF SEC Filings →EXCL SEC Filings →
→ RBRXF Financials→ RBRXF Earnings→ RBRXF Insider Trades

Frequently Asked Questions

RBRXF SEC Filings · 8 questions

Rhino Biotech Limited (RBRXF) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 151 filings and access original documents at no cost. Rhino Biotech Limited's CIK is 0001278465.

RBRXF SEC filingsRhino Biotech Limited SEC documentsfind RBRXF 10-K